Drägerwerk AG & Co. KGaA (DGWPF) Stock Price & Analysis
Drägerwerk AG & Co. KGaA (DGWPF) — price $83.34 (0.00%), as of the Nov 19, 2026 trading session; market cap $1.56B.
Educational signal · not a buy or sell recommendation · How to read this
Drägerwerk AG & Co. KGaA · DGWPF
Drägerwerk AG & Co. KGaA is a global medical and safety technology company, providing system solutions and devices for emergency medicine, intensive care, and personal protection. The company's diverse portfolio addresses critical needs in both healthcare and industrial safety sectors worldwide.
Price as of Nov 19, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $83.34 | |
| Change on the day | 0.00% | |
| Market capitalisation | $1.56B | |
| Price / earnings (trailing) | 12.35 | |
| Shares traded on the day | 216 |
Price & events
Other perspectives
Council score for Drägerwerk AG & Co. KGaA (DGWPF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Drägerwerk AG & Co. KGaA (DGWPF), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Drägerwerk AG & Co. KGaA (DGWPF) is the company analyzed here. It employs 16,716 people. In Q3 FY2026 it reported revenue of €833M and net income of €33M. The market values it at $1.56B.
What do the latest results show for Drägerwerk AG & Co. KGaA (DGWPF)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of €833M. Against analyst estimates the company has EPS beat 1 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | €833M | €33M | €1.77 (diluted) |
| Q2 FY2026 | €846M | €29M | €1.57 (diluted) |
| Q1 FY2026 | €759M | €11M | €0.61 (diluted) |
| Q4 FY2025 | €1.14B | €95M | €5.05 (diluted) |
What are the financial strengths and risks for Drägerwerk AG & Co. KGaA (DGWPF)?
Short answer · as of
The distress and quality screens read Altman Z 2.85 · Piotroski F 6. Trailing ratios: ROE 10.2% · ROA 5.2% · current ratio 2.07 · earnings yield 8.9% · free-cash-flow yield 13.4%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held DGWPF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported DGWPF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About DGWPF
These answers are editorial: 2 of these 8 answers are drawn from the DGWPF research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 6 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is DGWPF a good stock to buy?
Stock Expert AI does not rate DGWPF buy, sell or hold. Drägerwerk AG & Co. KGaA has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the DGWPF stock price today?
The last price recorded for Drägerwerk AG & Co. KGaA (DGWPF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the implications of Drägerwerk AG & Co. KGaA's OTC listing for investors?
Drägerwerk AG & Co. KGaA's listing on the OTC market, particularly in the 'OTC Other' tier with an 'Unknown' disclosure status, carries several implications for investors.
What are the main risks for DGWPF?
The primary risks for DGWPF stem from its dual market exposure and OTC listing. A significant risk is the cyclical nature of government and hospital spending, which directly impacts demand for its medical devices. Economic downturns or budget constraints in healthcare sectors globally could lead to reduced sales.
What are the key factors to evaluate for DGWPF?
Evaluate DGWPF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Not financial advice.
How frequently does DGWPF data refresh on this page?
DGWPF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven DGWPF's recent stock price performance?
Drägerwerk AG & Co. KGaA (DGWPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Long-standing global presence and strong brand recognition in both medical and safety technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DGWPF overvalued or undervalued right now?
The trailing P/E of Drägerwerk AG & Co. KGaA (DGWPF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 10 from Financial Modeling Prep (FMP) and 3 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com